Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments (Details Narrative)

v3.21.2
Derivative Financial Instruments (Details Narrative) - USD ($)
Jan. 02, 2020
May 18, 2018
Amended and Restated Loan Agreement [Member]    
Warrants to acquire of common stock   320,000
Warrant exercise price   $ 0.10
Derivative liability   $ 30,013
Acquisition Note [Member]    
Warrants to acquire of common stock 5,000,000  
Warrant exercise price $ 0.10  
Derivative liability $ 144,259  
Warrants term 36 months